ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Charges Against CC Probed; Most Found Invalid

March 31, 1978

ASCO Supports CT Scans For Colorectal Screening

November 25, 2005

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006

Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center

March 5, 1999

NCI FY94 Budget To Fund 860 Grants, Increase Prevention, Construction Money

December 3, 1993